Home » Stocks » ACST

Acasti Pharma Inc. (ACST)

Stock Price: $0.290 USD 0.037 (14.62%)
Updated November 30, 4:00 PM EST - Market closed
After-hours: $0.286 -0.004 (-1.38%) Nov 30, 5:47 PM

Stock Price Chart

Key Info

Market Cap 28.09M
Revenue (ttm) n/a
Net Income (ttm) -5.71M
Shares Out 96.87M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 30
Last Price $0.290
Previous Close $0.253
Change ($) 0.037
Change (%) 14.62%
Day's Open 0.260
Day's Range 0.253 - 0.295
Day's Volume 16,730,409
52-Week Range 0.182 - 2.870

More Stats

Market Cap 28.09M
Enterprise Value 16.66M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 96.87M
Float n/a
EPS (basic) n/a
EPS (diluted) -0.07
FCF / Share -0.19
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 457,066
Short Ratio 0.18
Short % of Float n/a
Beta 1.22
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 2.63
Revenue n/a
Operating Income -21.87M
Net Income -5.71M
Free Cash Flow -18.43M
Net Cash 11.43M
Net Cash / Share 0.12
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -52.55%
ROE -166.09%
ROIC 806.90%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (2)

Buy 0
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Hold

Price Target

$0.25*
Low
0.25
Current: $0.290
High
0.25
Target: 0.25
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions CAD.

Financial Overview

Year201920182017201620152014
Revenue------
Operating Income-24.44-34.41-19.70-11.21-9.61-12.40
Net Income-25.51-39.37-21.50-11.25-6.32-1.66
Shares Outstanding84.5854.2917.4911.0910.6610.62
Earnings Per Share-0.30-0.73-1.23-1.01-0.59-0.16
Operating Cash Flow-22.94-24.79-21.50-11.25-6.57-7.20
Capital Expenditures-0.32-0.53-0.46-2.53-0.28-0.04
Free Cash Flow-23.26-25.32-21.96-13.77-6.85-7.23
Cash & Equivalents14.2425.768.22-10.47-
Total Debt0.151.361.61---
Net Cash / Debt14.0924.406.61-10.47-
Assets22.8536.9022.96-28.52-
Liabilities9.8625.8514.74-1.30-
Book Value12.9911.058.22-27.22-
Numbers in millions CAD, except per-share numbers.

Company Profile

Company Details

Full Name Acasti Pharma Inc.
Country Canada
Employees 32
CEO Janelle D'Alvise

Stock Information

Ticker Symbol ACST
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ACST

Description

Acasti Pharma, a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada.